Patients treated with Merck and Moderna's experimental melanoma vaccine were less likely to develop distant metastatic recurrence than untreated trial participants
Agree
Disagree
Overview
Debates
Related claims
Topics
Best
Space b5a31f
Loading debates…
Opening sign-in…